Innovative Clinical Science. Improved Patient Care.

We focus our research and development practice on discovering and developing new medicines for unmet medical needs. Right now, the Genentech Research and Early Development pipeline has more than 20 new molecular entities in clinical development.

By The Numbers

39
Medicines on the market
45
Molecules in our pipeline
785K
Square feet devoted to research